Close Menu

NEW YORK (GenomeWeb) – CooperSurgical is exiting its genetic carrier screening and noninvasive prenatal testing business, the firm said in a regulatory filing on Friday.

CooperGenomics, a unit of CooperSurgical, itself part of the Cooper Companies, had been offering a carrier screening test called CarrierMap, which tested for more than 300 genetic conditions, as well as an NIPT called ChromoMap, which tested for fetal trisomies 21, 18, and 13 and, optionally, a number of sex chromosome aneuploidies and microdeletions.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.